Trial intelligence / Profile preview

Effects of Hyperoxia on Haemostasis, Inflammation and Reactive Oxygen Species in Healthy Volunteers

2015-003962-10Phase 4Completed

Sponsor
Medical University of Vienna
Start
Oct 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of oxygen (2 arms), sponsored by Medical University of Vienna. Primary endpoint: Reactive oxygen species generation under hyperoxia. Started Oct 2015; status: completed.

02

Drugs

oxygen

Beyond the preview

Go deeper on 2015-003962-10.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-003962-10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call